PRESS RELEASE published on 04/10/2025 at 15:00, 7 months 25 days ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
BRIEF published on 03/27/2025 at 07:50, 8 months 9 days ago Eckert & Ziegler annonce une année record en 2024 Eckert & Ziegler Résultats Financiers 2024 Secteur Médical Produits Isotopiques Prévisions Pour 2025
BRIEF published on 03/27/2025 at 07:50, 8 months 9 days ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE published on 03/27/2025 at 07:45, 8 months 9 days ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 8 months 11 days ago Eckert & Ziegler fournira de l'actinium-225 à Actinium Pharmaceuticals Essais Cliniques Leucémie Myéloïde Aiguë Approvisionnement En Actinium 225 Radiothérapie Ciblée Pénurie Mondiale
BRIEF published on 03/25/2025 at 09:35, 8 months 11 days ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
PRESS RELEASE published on 03/25/2025 at 09:30, 8 months 11 days ago Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities Eckert & Ziegler SE to supply Actinium Pharmaceuticals with Ac-225 for comprehensive development activities, targeting cancer treatment with radiotherapies Cancer Treatment Eckert & Ziegler SE Radiotherapy Ac-225 Actinium Pharmaceuticals
BRIEF published on 03/20/2025 at 14:05, 8 months 16 days ago Eckert & Ziegler s'associe à AtomVie pour l'approvisionnement en lutétium-177 Produits Radiopharmaceutiques Theralugand Lutécium-177 Accord Mondial Partenariat AtomVie
BRIEF published on 03/20/2025 at 14:05, 8 months 16 days ago Eckert & Ziegler Partner with AtomVie on Lutetium-177 Supply Radiopharmaceuticals Lutetium-177 Theralugand Global Agreement AtomVie Partnership
PRESS RELEASE published on 03/20/2025 at 14:00, 8 months 16 days ago Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply Eckert & Ziegler SE and AtomVie Global Radiopharma sign a global agreement for Lutetium-177 supply, enhancing radiopharmaceutical development and manufacturing Eckert & Ziegler SE Lutetium-177 Global Agreement AtomVie Global Radiopharma Radiopharmaceutical
Published on 12/05/2025 at 15:45, 15 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 15 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 25 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:00, 1 hour ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 15:43, 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 12/05/2025 at 15:42, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Big Yellow Group plc
Published on 12/05/2025 at 15:10, 49 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 49 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 2 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 15 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 15 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
